首页> 外文期刊>Scientific reports. >Ectopic expression of Cripto-1 in transgenic mouse embryos causes hemorrhages, fatal cardiac defects and embryonic lethality
【24h】

Ectopic expression of Cripto-1 in transgenic mouse embryos causes hemorrhages, fatal cardiac defects and embryonic lethality

机译:Cripto-1在转基因小鼠胚胎中的异位表达导致出血,致命的心脏缺陷和胚胎致死率

获取原文
           

摘要

Targeted disruption of Cripto-1 in mice caused embryonic lethality at E7.5, whereas we unexpectedly found that ectopic Cripto-1 expression in mouse embryos also led to embryonic lethality, which prompted us to characterize the causes and mechanisms underlying embryonic death due to ectopic Cripto-1 expression. RCLG/EIIa-Cre embryos displayed complex phenotypes between embryonic day 14.5 (E14.5) and E17.5, including fatal hemorrhages (E14.5-E15.5), embryo resorption (E14.5-E17.5), pale body surface (E14.5-E16.5) and no abnormal appearance (E14.5-E16.5). Macroscopic and histological examination revealed that ectopic expression of Cripto-1 transgene in RCLG/EIIa-Cre embryos resulted in lethal cardiac defects, as evidenced by cardiac malformations, myocardial thinning, failed assembly of striated myofibrils and lack of heartbeat. In addition, Cripto-1 transgene activation beginning after E8.5 also caused the aforementioned lethal cardiac defects in mouse embryos. Furthermore, ectopic Cripto-1 expression in embryonic hearts reduced the expression of cardiac transcription factors, which is at least partially responsible for the aforementioned lethal cardiac defects. Our results suggest that hemorrhages and cardiac abnormalities are two important lethal factors in Cripto-1 transgenic mice. Taken together, these findings are the first to demonstrate that sustained Cripto-1 transgene expression after E11.5 causes fatal hemorrhages and lethal cardiac defects, leading to embryonic death at E14.5-17.5.
机译:小鼠Cripto-1的定向破坏导致E7.5处的胚胎致死率,而我们意外地发现小鼠胚胎中异位的Cripto-1表达也导致胚胎致死率,这促使我们表征异位导致胚胎死亡的原因和机制Cripto-1表达。 RCLG / EIIa-Cre胚胎在胚胎第14.5天(E14.5)和E17.5之间显示复杂的表型,包括致命性出血(E14.5-E15.5),胚胎吸收(E14.5-E17.5),苍白的身体表面(E14.5-E16.5),无异常外观(E14.5-E16.5)。宏观和组织学检查显示,RCLG / EIIa-Cre胚胎中Cripto-1转基因的异位表达导致致命的心脏缺陷,如心脏畸形,心肌变薄,横纹肌原纤维组装失败和心跳不足所证明。此外,E8.5之后开始的Cripto-1转基因激活也引起了小鼠胚胎中上述致命的心脏缺陷。此外,在胚胎心脏中异位的Cripto-1表达降低了心脏转录因子的表达,这至少部分负责上述致命的心脏缺陷。我们的结果表明,出血和心脏异常是Cripto-1转基因小鼠的两个重要致死因素。综上所述,这些发现是第一个证明E11.5之后持续的Cripto-1转基因表达引起致命性出血和致命性心脏缺陷,从而导致E14.5-17.5胚胎死亡的研究。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号